Literature DB >> 19129610

Administration of anti-Reg I and anti-PAPII antibodies worsens pancreatitis.

Domenico Viterbo1, Gordon E Callender, Theresa DiMaio, Cathy M Mueller, Tamar Smith-Norowitz, Michael E Zenilman, Martin H Bluth.   

Abstract

CONTEXT: The regeneration protein family (Reg), which includes Reg I and PAPII, is expressed in pancreas acinar cells, and increases in acute pancreatitis. We have demonstrated that Reg gene knockdown worsens severity of acute pancreatitis in the rat and hypothesize that the proteins offer a protective effect in this disease.
OBJECTIVE: We investigated the ability of anti-Reg and anti-PAP antibody to neutralize pancreatic Reg protein and affect pancreatitis severity. INTERVENTION: Pancreatitis was induced in rats by retrograde ductal injection of 4% sodium taurocholate. ANIMALS: Eighty-four rats: 48 with induced pancreatitis, 30 sham operated, and 6 normal animals.
SETTING: Intraductal anti-Reg I and/or anti-PAPII antibody was administered at induced pancreatitis and sham operated subgroups of 6 rats each. MAIN OUTCOME MEASURE: Serum and pancreata were harvested 24 and/or 48 hours later and assessed for pancreatitis severity by pancreatic wet weight, serum C-reactive protein (CRP), amylase, PAPII levels, and histopathology.
RESULTS: Animals induced with pancreatitis with administration of anti-Reg/PAP antibodies had significantly higher wet weights compared with taurocholate and histopathological analysis revealed that anti-Reg/PAP treated animals had worse tissue inflammation and necrosis compared with controls. Serum CRP, amylase, and Reg levels did not significantly differ between experimental and sham control groups.
CONCLUSIONS: Administration of anti-Reg/PAP antibody worsened taurocholate-induced organ specific pancreatitis. These data suggest that the Reg family of proteins is protective in acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129610      PMCID: PMC2666878     

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  30 in total

1.  Pancreatic regenerating protein (reg I) and reg I receptor mRNA are upregulated in rat pancreas after induction of acute pancreatitis.

Authors:  Martin H Bluth; Sameer A Patel; Brian K Dieckgraefe; Hiroshi Okamoto; Michael E Zenilman
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.

Authors:  C Niederau; R A Liddle; L D Ferrell; J H Grendell
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Production and characterization of Reg knockout mice: reduced proliferation of pancreatic beta-cells in Reg knockout mice.

Authors:  Michiaki Unno; Koji Nata; Naoya Noguchi; Yoichi Narushima; Takako Akiyama; Takayuki Ikeda; Kei Nakagawa; Shin Takasawa; Hiroshi Okamoto
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

4.  A novel gene activated in regenerating islets.

Authors:  K Terazono; H Yamamoto; S Takasawa; K Shiga; Y Yonemura; Y Tochino; H Okamoto
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

5.  Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha upregulation, processing, and antiapoptotic activity.

Authors:  Brian K Dieckgraefe; Dan L Crimmins; Vonnie Landt; Courtney Houchen; Shrikant Anant; Rhonda Porche-Sorbet; Jack H Ladenson
Journal:  J Investig Med       Date:  2002-11       Impact factor: 2.895

6.  Localization of rat pancreatitis-associated protein during bile salt-induced pancreatitis.

Authors:  J Morisset; J Iovanna; G Grondin
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

7.  Targeted inhibition of gene expression of pancreatitis-associated proteins exacerbates the severity of acute pancreatitis in rats.

Authors:  H Zhang; E Kandil; Y-Y Lin; G Levi; M E Zenilman
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

8.  Isolation, characterization, and distribution of an unusual pancreatic human secretory protein.

Authors:  J Gross; R I Carlson; A W Brauer; M N Margolies; A L Warshaw; J R Wands
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Human pancreatic reg protein immunoenzymatic assay and molecular form in serum.

Authors:  J Carrère; O Guy-Crotte; C Figarella
Journal:  Clin Chim Acta       Date:  1998-05-25       Impact factor: 3.786

10.  REG I as a marker for human pancreatic acinoductular cells.

Authors:  Ekmel Tezel; Tetsuro Nagasaka; Gaye Tezel; Tetsuya Kaneko; Shin Takasawa; Hiroshi Okamoto; Akimasa Nakao
Journal:  Hepatogastroenterology       Date:  2004 Jan-Feb
View more
  5 in total

1.  Acute pancreatitis in aging animals: loss of pancreatitis-associated protein protection?

Authors:  Sophia Fu; Albert Stanek; Cathy M Mueller; Nefertti A Brown; Chongmin Huan; Martin H Bluth; Michael E Zenilman
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

2.  Comparison of His and GST tagged versions of recombinant pancreatitis associated protein 2 in modulation of inflammatory responses.

Authors:  Domenico Viterbo; Michael E Zenilman; Martin H Bluth
Journal:  Inflamm Res       Date:  2010-04-16       Impact factor: 4.575

3.  A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway.

Authors:  Xiaolu Yang; Huiyi Jin; Kun Liu; Qing Gu; Xun Xu
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

Review 4.  Four Decades After the Discovery of Regenerating Islet-Derived (Reg) Proteins: Current Understanding and Challenges.

Authors:  Zijing Chen; Shawna Downing; Emmanuel S Tzanakakis
Journal:  Front Cell Dev Biol       Date:  2019-10-22

5.  Serum REG Iα as a potential novel biomarker in cancer: An observational study.

Authors:  Yumin Zhang; Xuelu Yuan; Xiangyun Zhu; Qian Wang; Xuebing Yu; Qiong Wei; Ling Li
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.